Literature DB >> 10618339

Role of endothelial cell denudation and smooth muscle cell dedifferentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: therapeutic implications.

Y Sasaki1, S Suehiro, A E Becker, H Kinoshita, M Ueda.   

Abstract

OBJECTIVE: To provide better insights into the genesis of neointimal thickening in human vein grafts early after surgery.
DESIGN: Retrospective study.
SETTING: Tertiary referral centre.
SUBJECTS: 18 distal anastomotic sites of patent grafts, obtained at necropsy from eight patients who died over differing periods (ranging from two days to nine months) after the procedure. MAIN OUTCOME MEASURES: Immunohistochemical evaluation of smooth muscle cell phenotype modulation in relation to proliferative activity.
RESULTS: The earliest changes are characterised by loss of surface lining endothelial cells and insudation of blood corpuscular elements admixed with fibrin-platelet thrombus. At sites of injury vimentin positive and actin negative spindle shaped cells appear in the intima, while the related pre-existent media shows focal absence of actin positive smooth muscle cells. Proliferative activity colocalises at these sites. With time distinct neointimal thickening occurs, associated with disappearance of proliferative activity and a phenotypic shift of the smooth muscle cells.
CONCLUSIONS: The observation that luminal endothelial cell denudation, with insudation of the intima with blood elements, occurs in the very early stages suggests that these phenomena are responsible for the observed dedifferentiation of pre-existent smooth muscle cells, known to be a prerequisite for cell proliferation and the evolution of intimal thickening. It is likely, therefore, that platelet released growth factors play a pivotal role, which thus may provide a target for preventive pharmacological intervention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618339      PMCID: PMC1729291          DOI: 10.1136/heart.83.1.69

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

1.  Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition.

Authors:  M Ueda; A E Becker; T Tsukada; F Numano; T Fujimoto
Journal:  Circulation       Date:  1991-04       Impact factor: 29.690

2.  Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months.

Authors:  J Amano; A Suzuki; M Sunamori; T Tsukada; F Numano
Journal:  Am J Cardiol       Date:  1991-06-01       Impact factor: 2.778

3.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

4.  Pathologic changes in aortocoronary saphenous vein grafts.

Authors:  K K Unni; B A Kottke; J L Titus; R L Frye; R B Wallace; A L Brown
Journal:  Am J Cardiol       Date:  1974-10-03       Impact factor: 2.778

5.  Pathologic changes in aortic-coronary arterial saphenous vein grafts.

Authors:  Z Vlodaver; J E Edwards
Journal:  Circulation       Date:  1971-10       Impact factor: 29.690

6.  Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media.

Authors:  G Gabbiani; O Kocher; W S Bloom; J Vandekerckhove; K Weber
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

7.  Histologic fate of the venous coronary artery bypass in dogs.

Authors:  W R Brody; W W Angeli; J C Kosek
Journal:  Am J Pathol       Date:  1972-01       Impact factor: 4.307

8.  The Watanabe heritable hyperlipidemic rabbit is a suitable experimental model to study differences in tissue response between intimal and medical injury after balloon angioplasty.

Authors:  M Takagi; M Ueda; A E Becker; K Takeuchi; T Takeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-12       Impact factor: 8.311

9.  Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments of veins.

Authors:  J M Kalan; W C Roberts
Journal:  Am Heart J       Date:  1990-05       Impact factor: 4.749

10.  A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes.

Authors:  A M Gown; A M Vogel; D Gordon; P L Lu
Journal:  J Cell Biol       Date:  1985-03       Impact factor: 10.539

View more
  9 in total

1.  Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome.

Authors:  Budi Y Setianto; Anggoro B Hartopo; Putrika P R Gharini; Dyah W Anggrahini; Bambang Irawan
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

2.  Mechanism and effect of thrombospondin-4 polymorphisms on neutrophil function.

Authors:  Elzbieta Pluskota; Olga I Stenina; Irene Krukovets; Dorota Szpak; Eric J Topol; Edward F Plow
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

3.  Scaffold-free in vitro arterial mimetics: the importance of smooth muscle-endothelium contact.

Authors:  Somali Chaterji; Kinam Park; Alyssa Panitch
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

Review 4.  Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications.

Authors:  Christopher D Owens
Journal:  J Vasc Surg       Date:  2009-10-17       Impact factor: 4.268

5.  The consequence of biologic graft processing on blood interface biocompatibility and mechanics.

Authors:  Aurore B Van de Walle; Joseph S Uzarski; Peter S McFetridge
Journal:  Cardiovasc Eng Technol       Date:  2015-09       Impact factor: 2.495

6.  Slow and sustained nitric oxide releasing compounds inhibit multipotent vascular stem cell proliferation and differentiation without causing cell death.

Authors:  Brandon M Curtis; Kyle Alexander Leix; Yajing Ji; Richard Samuel Elliot Glaves; David E Ash; Dillip K Mohanty
Journal:  Biochem Biophys Res Commun       Date:  2014-05-27       Impact factor: 3.575

7.  In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.

Authors:  Christopher D Owens; Nicole Wake; Michael S Conte; Marie Gerhard-Herman; Joshua A Beckman
Journal:  J Vasc Surg       Date:  2009-08-12       Impact factor: 4.268

8.  Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial.

Authors:  Ralf E Harskamp; John H Alexander; Phillip J Schulte; Colleen M Brophy; Michael J Mack; Eric D Peterson; Judson B Williams; C Michael Gibson; Robert M Califf; Nicholas T Kouchoukos; Robert A Harrington; T Bruce Ferguson; Renato D Lopes
Journal:  JAMA Surg       Date:  2014-08       Impact factor: 14.766

Review 9.  Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.

Authors:  Alistair J Geraghty; Karen Welch
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.